All In Biotech

Drug Trial Radar · NCT05015686

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

A Randomized, Blind, Controlled Clinical Trial to Evaluate Safety and Immunogenicity of Live Attenuated Varicella Vaccine After a Two-dose Vaccination Course in Healthy Population Aged ≥13 Years Old

Last checked: Nov 19, 2026Latest source record: Mar 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 2,400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,400

Planned (sponsor's estimate)

Start

Sep 30, 2021

Primary completion

Feb 9, 2022

Study completion Sep 20, 2026

Sponsor

Sponsor type
Industry
First posted
Aug 20, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 13 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This a randomized, blind, controlled clinical trial of live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd .The purpose of this study is to evaluate the immunogenicity of a two doses vaccination of investigational vaccine with 0,28 day, 0,42 day and 0,56 day immunization schedule in population aged ≥13 years old.

Conditions

  • Varicella

Interventions

  • Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., LtdBiological

    live varicella-zoster virus in 0·5 mL of sucrose, sodium glutamate,sodium chloride,potassium chloride,sodium dihydrogen phosphate, potassium dihydrogen phosphate and injection water per injection

  • Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,LtdBiological

    live varicella-zoster virus in trehalose,human serum albumin,sodium glutamate,sucrose,glucose,carbamide,arginine and injection water per injection

  • Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., LtdBiological

    live varicella-zoster virus in 0·5 mL of sucrose, sodium glutamate,sodium chloride,potassium chloride,sodium dihydrogen phosphate, potassium dihydrogen phosphate and injection water per injection

  • PlaceboBiological

    Sodium chloride and distilled water

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Seroconversion rate of the antibodyTime frame: Day 28 after the whole schedule
  2. GMT of the antibodyTime frame: Day 28 after the whole schedule

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Yucheng Center for Disease Control and Prevention

    Shangqiu, Henan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.